Guidance for Submission v 4 - SFDA
Guidance for Submission
Version 4.0
March 2014
This page is left blank intentionally
Mar 2014
Saudi Food & Drug Authority
2
Guidance for Submission
Version 4.0
Drug Sector Saudi Food & Drug Authority
Kingdom of Saudi Arabia
Please visit SFDA's website at for the latest update
Mar 2014
Saudi Food & Drug Authority
3
Drug Sector
Vision & Mission
Vision
To be the leading regional Drug Regulatory Authority for pharmaceuticals and cosmetic products, with professional excellence and services that contribute to the protection and advancement of public health in the Kingdom of Saudi Arabia.
K
Mission
Protecting public health by ensuring safety, quality, efficacy and accessibility of human, veterinary drugs and biological products, and safety of cosmetics, through administration of a national regulatory system which is consistent with international best practice. Through our mission, we also provide accurate and scientific-based information to the public and healthcare professionals.
.
Mar 2014
Saudi Food & Drug Authority
4
Document Control
Version
1.0 1.1 1.2 1.3
2.0 2.1 2.2 2.3 2.4
3.0 3.1 3.2 4.0
Date
11/05/2009 20/05/2009 06/06/2009 28/06/2009 08/07/2009 20/7/2010 18/9/2011 2/12/2011 7/12/2011 17/12/2011 08/05/2012 10/10/2012 16/03/2014
Author(s)
Licensing department Licensing department Licensing department Licensing department Licensing department Regulatory Affairs Regulatory Affairs Regulatory Affairs Regulatory Affairs Regulatory Affairs Regulatory Affairs Regulatory Affairs Regulatory Affairs
Comments
Initial draft for internal consultation Draft revision Draft revision Revisions after management discussion Published for comments Internal revision External consultation Final revision Approved by management Published Updated and Published version Updated version Final version posted
Mar 2014
Saudi Food & Drug Authority
5
................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
- fda regulations and process validation considerations
- overview of the fda submission process nci sbir
- cmc regulatory considerations for oligonucleotide drug
- electronic submissions to fda guidelines and best practices
- an fda submission experience using the cdisc standards
- 2018 nda submission guidelines
- guidance for submission v 4 sfda
- preparing protocol documents for ectd submissions to the fda